A 6-year prospective clinical cohort study on the bidirectional association between frailty and depressive disorder

Carregando...
Imagem de Miniatura
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
VOSHAAR, Richard C. Oude
DIMITRIADIS, Menelaos
VANDENBRINK, Rob H. S.
APRAHAMIAN, Ivan
MARIJNISSEN, Radboud M.
HOOGENDIJK, Emiel O.
RHEBERGEN, Didi
JEURING, Hans W.
Citação
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, v.36, n.11, p.1699-1707, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction Depressive disorder has been conceptualised as a condition of accelerated biological ageing. We operationalised a frailty index (FI) as marker for biological ageing aimed to explore the bidirectional, longitudinal association between frailty and either depressive symptoms or depressive disorder. Methods A cohort study with 6-year follow-up including 377 older (>= 60 years) outpatients with a DSM-IV-defined depressive disorder and 132 never-depressed controls. Site visits at baseline, 2 and 6-year follow-up were conducted and included the CIDI 2.0 to assess depressive disorder and relevant covariates. Depressive symptom severity and mortality were assessed every 6 months by mail and telephone. A 41-item FI was operationalised and validated against the 6-year morality rate by Cox regression (HRFI = 1.04 [95% CI: 1.02-1.06]). Results Cox regression showed that a higher FI was associated with a lower chance of remission among depressed patients (HRFI = 0.98 [95% CI: 0.97-0.99]). Nonetheless, this latter effect disappeared after adjustment for baseline depressive symptom severity. Linear mixed models showed that the FI increased over time in the whole sample (B[SE] = 0.94 (0.12), p < .001) with a differential impact of depressive symptom severity and depressive disorder. Higher baseline depressive symptom severity was associated with an attenuated and depressive disorder with an accelerated increase of the FI over time. Conclusions The sum score of depression rating scales is likely confounded by frailty. Depressive disorder, according to DSM-IV criteria, is associated with accelerated biological ageing. This argues for the development of multidisciplinary geriatric care models incorporating frailty to improve the overall outcome of late-life depression.
Palavras-chave
ageing, biological ageing, depressive disorder, frailty, frailty index
Referências
  1. Almeida OP, 2015, J AM MED DIR ASSOC, V16, P296, DOI 10.1016/j.jamda.2014.10.023
  2. Aprahamian Ivan, 2020, Int Psychogeriatr, P1, DOI 10.1017/S1041610220003403
  3. Armstrong JJ, 2015, J GERONTOL A-BIOL, V70, P125, DOI 10.1093/gerona/glu089
  4. Arts MHL, 2015, J AM GERIATR SOC, V63, P1652, DOI 10.1111/jgs.13528
  5. Benraad CEM, 2020, INT J GERIATR PSYCH, V35, P617, DOI 10.1002/gps.5278
  6. Benraad CEM, 2016, INT J GERIATR PSYCH, V31, P990, DOI 10.1002/gps.4443
  7. BLAZER D, 1991, J GERONTOL, V46, pM210, DOI 10.1093/geronj/46.6.M210
  8. Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x
  9. Brown PJ, 2021, AM J GERIAT PSYCHIAT, V29, P944, DOI 10.1016/j.jagp.2020.12.024
  10. Choi KW, 2019, JAMA PSYCHIAT, V76, P399, DOI 10.1001/jamapsychiatry.2018.4175
  11. Collard RM, 2017, EUR PSYCHIAT, V43, P66, DOI 10.1016/j.eurpsy.2017.01.003
  12. Collard RM, 2015, J AM MED DIR ASSOC, V16, P509, DOI 10.1016/j.jamda.2015.01.088
  13. Collard RM, 2014, AGING MENT HEALTH, V18, P570, DOI 10.1080/13607863.2013.827628
  14. Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x
  15. Comijs Hannie C, 2011, BMC Res Notes, V4, P524, DOI 10.1186/1756-0500-4-524
  16. Dent E, 2019, J NUTR HEALTH AGING, V23, P771, DOI 10.1007/s12603-019-1273-z
  17. Diniz BS, 2018, AM J GERIAT PSYCHIAT, V26, P1097, DOI 10.1016/j.jagp.2018.07.005
  18. Everaert J, 2017, CLIN PSYCHOL REV, V58, P33, DOI 10.1016/j.cpr.2017.09.005
  19. Feng L, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2013.10.001
  20. Gavrilov LA, 1991, BIOL LIFE SPAN QUANT
  21. Han LKM, 2019, PSYCHONEUROENDOCRINO, V106, P293, DOI 10.1016/j.psyneuen.2019.04.004
  22. Hoogendijk EO, 2018, AGE AGEING, V47, P727, DOI 10.1093/ageing/afy081
  23. Hoogendijk EO, 2015, J AM MED DIR ASSOC, V16, P855, DOI 10.1016/j.jamda.2015.04.007
  24. Jeuring HW, 2018, AM J GERIAT PSYCHIAT, V26, P985, DOI 10.1016/j.jagp.2018.05.005
  25. Kojima G, 2018, AGE AGEING, V47, P193, DOI 10.1093/ageing/afx162
  26. Kokkeler K J E, 2020, Psychol Med, P1, DOI 10.1017/S0033291720002159
  27. Kokkeler KJE, 2019, INT J GERIATR PSYCH, V34, P1226, DOI 10.1002/gps.5121
  28. Lohman M, 2016, J GERONTOL B-PSYCHOL, V71, P630, DOI 10.1093/geronb/gbu180
  29. Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033
  30. Mezuk B, 2013, AM J GERIAT PSYCHIAT, V21, P560, DOI 10.1016/j.jagp.2012.12.019
  31. Miloyan B, 2017, WORLD PSYCHIATRY, V16, P219, DOI 10.1002/wps.20439
  32. Mitnitski A, 2016, BIOGERONTOLOGY, V17, P199, DOI 10.1007/s10522-015-9583-y
  33. Mitnitski A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0400-x
  34. Mitnitski A, 2013, BIOGERONTOLOGY, V14, P709, DOI 10.1007/s10522-013-9446-3
  35. Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1
  36. Negm AM, 2019, J AM MED DIR ASSOC, V20, P1190, DOI 10.1016/j.jamda.2019.08.009
  37. Rockwood K, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43068
  38. Rockwood K, 2019, MECH AGEING DEV, V180, P107, DOI 10.1016/j.mad.2019.04.005
  39. Rockwood K, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1223-3
  40. Rockwood K, 2010, J AM GERIATR SOC, V58, P318, DOI 10.1111/j.1532-5415.2009.02667.x
  41. Rozing MP, 2019, PSYCHONEUROENDOCRINO, V99, P20, DOI 10.1016/j.psyneuen.2018.08.029
  42. Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24
  43. Soysal P, 2017, AGEING RES REV, V36, P78, DOI 10.1016/j.arr.2017.03.005
  44. Stolz E, 2017, J EPIDEMIOL COMMUN H, V71, P73, DOI 10.1136/jech-2016-207712